Please provide your email address to receive an email when new articles are posted on . While there is a cross-section of drugs that are FDA-approved for the treatment of axial spondyloarthritis, ...
Please provide your email address to receive an email when new articles are posted on . Among patients diagnosed with definite axial SpA at baseline, 94% retained the diagnosis 2 years later. Features ...
The term axial spondyloarthritis covers both non-radiographic disease and radiographic disease (also known as ankylosing spondylitis). Some studies have been performed to investigate the prevalence of ...
Approximately one quarter of patients with psoriatic arthritis (PsA) exhibited axial involvement (axial PsA). Enthesitis, inflammatory bowel disease, and HLA-B27 positivity were associated with an ...
The American College of Rheumatology (ACR) has released new recommendations for the treatment of ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (SpA). The guideline was ...
MSD (Merck & Co., Inc.), a global healthcare leader working to help the world be well, announced that the European Commission approved Simponi (golimumab) for the treatment of adult patients with ...
Basel, June 17, 2020 — Novartis, a leader in rheumatology and immuno-dermatology, today announced that the US Food and Drug Administration (FDA) has approved Cosentyx ® (secukinumab) for the treatment ...
Ankylosing spondylitis and axial spondyloarthritis (non-radiographic) - adalimumab, etanercept infliximab and golimumab (inc rev TA143 and TA233): assessment report Ankylosing spondylitis and axial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results